-
1
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
2
-
-
0034648768
-
Atherosclerosis
-
Lusis AJ. Atherosclerosis. Nature 2000; 407:233-241.
-
(2000)
Nature
, vol.407
, pp. 233-241
-
-
Lusis, A.J.1
-
3
-
-
0033552883
-
Atherosclerosis: An inflammatory disease
-
Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
4
-
-
0026632822
-
Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells
-
Hurt-Camejo E, Camejo G, Rosengren B, et al. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992; 12:569-583.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 569-583
-
-
Hurt-Camejo, E.1
Camejo, G.2
Rosengren, B.3
-
5
-
-
0031877416
-
Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis
-
Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998; 139:205-222.
-
(1998)
Atherosclerosis
, vol.139
, pp. 205-222
-
-
Camejo, G.1
Hurt-Camejo, E.2
Wiklund, O.3
Bondjers, G.4
-
6
-
-
0037071843
-
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
-
Skalen K, Gustafsson M, Rydberg EK, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002; 417:750-754.
-
(2002)
Nature
, vol.417
, pp. 750-754
-
-
Skalen, K.1
Gustafsson, M.2
Rydberg, E.K.3
-
7
-
-
0142124855
-
Oxidized phospholipids as modulators of inflammation in atherosclerosis
-
Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 2003; 14:421-430.
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 421-430
-
-
Leitinger, N.1
-
9
-
-
0036853543
-
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
-
Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002; 8:1211-1217.
-
(2002)
Nat Med
, vol.8
, pp. 1211-1217
-
-
Steinberg, D.1
-
10
-
-
28444431551
-
Oxidized phospholipids as triggers of inflammation in atherosclerosis
-
Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 2005; 49:1063-1071.
-
(2005)
Mol Nutr Food Res
, vol.49
, pp. 1063-1071
-
-
Leitinger, N.1
-
11
-
-
32944464648
-
Pathogen recognition and innate immunity
-
Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
-
(2006)
Cell
, vol.124
, pp. 783-801
-
-
Akira, S.1
Uematsu, S.2
Takeuchi, O.3
-
12
-
-
30044442866
-
How Toll-like receptors signal: What we know and what we don't know
-
O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006; 18:3-9.
-
(2006)
Curr Opin Immunol
, vol.18
, pp. 3-9
-
-
O'Neill, L.A.1
-
13
-
-
3142724031
-
Toll-like receptor signalling
-
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 499-511
-
-
Akira, S.1
Takeda, K.2
-
14
-
-
20344389060
-
Toll-like receptors: Linking innate and adaptive immunity
-
Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol 2005; 560:11-18.
-
(2005)
Adv Exp Med Biol
, vol.560
, pp. 11-18
-
-
Pasare, C.1
Medzhitov, R.2
-
15
-
-
5444262511
-
Toll-like receptor control of the adaptive immune responses
-
Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-995.
-
(2004)
Nat Immunol
, vol.5
, pp. 987-995
-
-
Iwasaki, A.1
Medzhitov, R.2
-
16
-
-
5444234216
-
The interface between innate and adaptive immunity
-
Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004; 5:971-974.
-
(2004)
Nat Immunol
, vol.5
, pp. 971-974
-
-
Hoebe, K.1
Janssen, E.2
Beutler, B.3
-
17
-
-
8444252436
-
TLR signaling: An emerging bridge from innate immunity to atherogenesis
-
Michelsen KS, Doherty TM, Shah PK, Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J Immunol 2004; 173:5901-5907.
-
(2004)
J Immunol
, vol.173
, pp. 5901-5907
-
-
Michelsen, K.S.1
Doherty, T.M.2
Shah, P.K.3
Arditi, M.4
-
18
-
-
24144502438
-
Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: Toll receptors in atherogenesis
-
Tobias P, Curtiss LK. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res 2005; 46:404-411.
-
(2005)
J Lipid Res
, vol.46
, pp. 404-411
-
-
Tobias, P.1
Curtiss, L.K.2
-
19
-
-
0037163149
-
Innate and adaptive immunity in the pathogenesis of atherosclerosis
-
Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91:281-291.
-
(2002)
Circ Res
, vol.91
, pp. 281-291
-
-
Hansson, G.K.1
Libby, P.2
Schonbeck, U.3
Yan, Z.Q.4
-
20
-
-
4344627821
-
Endogenous ligands of Toll-like receptors
-
Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76:514-519.
-
(2004)
J Leukoc Biol
, vol.76
, pp. 514-519
-
-
Tsan, M.F.1
Gao, B.2
-
21
-
-
0037066041
-
Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation
-
Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002; 105:1158-1161.
-
(2002)
Circulation
, vol.105
, pp. 1158-1161
-
-
Edfeldt, K.1
Swedenborg, J.2
Hansson, G.K.3
Yan, Z.Q.4
-
22
-
-
0035910010
-
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL
-
Xu XH, Shah PK, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001; 104:3103-3108.
-
(2001)
Circulation
, vol.104
, pp. 3103-3108
-
-
Xu, X.H.1
Shah, P.K.2
Faure, E.3
-
23
-
-
19644390754
-
Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome
-
Methe H, Kim JO, Kofler S, et al. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation 2005; 111:2654-2661.
-
(2005)
Circulation
, vol.111
, pp. 2654-2661
-
-
Methe, H.1
Kim, J.O.2
Kofler, S.3
-
24
-
-
33644867555
-
Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease
-
Geng HL, Lu HQ, Zhang LZ, et al. Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease. Clin Exp Immunol 2006; 143:269-273.
-
(2006)
Clin Exp Immunol
, vol.143
, pp. 269-273
-
-
Geng, H.L.1
Lu, H.Q.2
Zhang, L.Z.3
-
25
-
-
33745053205
-
Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway
-
Harari OA, Alcaide P, Ahl D, et al. Absence of TRAM Restricts Toll-Like Receptor 4 Signaling in Vascular Endothelial Cells to the MyD88 Pathway. Circ Res 2006; 98:1134-1140.
-
(2006)
Circ Res
, vol.98
, pp. 1134-1140
-
-
Harari, O.A.1
Alcaide, P.2
Ahl, D.3
-
26
-
-
27644568878
-
Modulation of atherosclerosis in mice by Toll-like receptor 2
-
Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005; 115:3149-3156. This in-vivo study showed that TLR2 activation promotes atherosclerosis in an atherosclerosis-prone mouse model. Experiments with adoptive transfer of bone marrow suggest that endogenous ligands promote atherosclerosis by vascular TLR2 expression, while exogenous ligand administration provokes atherosclerosis dependent on TLR2 expression on bone marrow-derived cells.
-
(2005)
J Clin Invest
, vol.115
, pp. 3149-3156
-
-
Mullick, A.E.1
Tobias, P.S.2
Curtiss, L.K.3
-
27
-
-
0034084438
-
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
-
Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-191.
-
(2000)
Nat Genet
, vol.25
, pp. 187-191
-
-
Arbour, N.C.1
Lorenz, E.2
Schutte, B.C.3
-
28
-
-
0037130195
-
Toll-like receptor 4 polymorphisms and atherogenesis
-
Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192.
-
(2002)
N Engl J Med
, vol.347
, pp. 185-192
-
-
Kiechl, S.1
Lorenz, E.2
Reindl, M.3
-
29
-
-
1342278730
-
Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events
-
Ameziane N, Beillat T, Verpillat P, et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003; 23:e61-e64.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
-
-
Ameziane, N.1
Beillat, T.2
Verpillat, P.3
-
30
-
-
21344468658
-
Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS
-
Norata GD, Garlaschelli K, Ongari M, et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med 2005; 258:21-27.
-
(2005)
J Intern Med
, vol.258
, pp. 21-27
-
-
Norata, G.D.1
Garlaschelli, K.2
Ongari, M.3
-
31
-
-
11144229546
-
Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis
-
Zee RY, Hegener HH, Gould J, Ridker PM. Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke 2005; 36:154-157.
-
(2005)
Stroke
, vol.36
, pp. 154-157
-
-
Zee, R.Y.1
Hegener, H.H.2
Gould, J.3
Ridker, P.M.4
-
32
-
-
4043067215
-
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction
-
Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004; 25:1447-1453.
-
(2004)
Eur Heart J
, vol.25
, pp. 1447-1453
-
-
Edfeldt, K.1
Bennet, A.M.2
Eriksson, P.3
-
33
-
-
21544462582
-
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
-
Hamann L, Gomma A, Schroder NW, et al. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med 2005; 83:478-485.
-
(2005)
J Mol Med
, vol.83
, pp. 478-485
-
-
Hamann, L.1
Gomma, A.2
Schroder, N.W.3
-
34
-
-
31044445827
-
Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis
-
Hamann L, Glaeser C, Hamprecht A, et al. Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 2006; 364:303-307.
-
(2006)
Clin Chim Acta
, vol.364
, pp. 303-307
-
-
Hamann, L.1
Glaeser, C.2
Hamprecht, A.3
-
35
-
-
3242728901
-
Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways
-
Bjorkbacka H, Kunjathoor VV, Moore KJ, et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004; 10:416-421.
-
(2004)
Nat Med
, vol.10
, pp. 416-421
-
-
Bjorkbacka, H.1
Kunjathoor, V.V.2
Moore, K.J.3
-
36
-
-
3242710174
-
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
-
Michelsen KS, Wong MH, Shah PK, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A 2004; 101:10679-10684.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 10679-10684
-
-
Michelsen, K.S.1
Wong, M.H.2
Shah, P.K.3
-
37
-
-
0037388984
-
Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice
-
Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23:656-660.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 656-660
-
-
Kirii, H.1
Niwa, T.2
Yamada, Y.3
-
38
-
-
0038094522
-
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
-
Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003; 59:234-240.
-
(2003)
Cardiovasc Res
, vol.59
, pp. 234-240
-
-
Elhage, R.1
Jawien, J.2
Rudling, M.3
-
39
-
-
0034678402
-
Infectious agents are not necessary for murine atherogenesis
-
Wright SD, Burton C, Hernandez M, et al. Infectious agents are not necessary for murine atherogenesis. J Exp Med 2000; 191:1437-1442.
-
(2000)
J Exp Med
, vol.191
, pp. 1437-1442
-
-
Wright, S.D.1
Burton, C.2
Hernandez, M.3
-
40
-
-
0034516874
-
Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months
-
Liu L, Hu H, Ji H, et al. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem 2000; 215:123-128.
-
(2000)
Mol Cell Biochem
, vol.215
, pp. 123-128
-
-
Liu, L.1
Hu, H.2
Ji, H.3
-
41
-
-
0033051627
-
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
-
Moazed TC, Campbell LA, Rosenfeld ME, et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 1999; 180:238-241.
-
(1999)
J Infect Dis
, vol.180
, pp. 238-241
-
-
Moazed, T.C.1
Campbell, L.A.2
Rosenfeld, M.E.3
-
42
-
-
0035012440
-
Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice
-
Hsich E, Zhou YF, Paigen B, et al. Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 2001; 156:23-28.
-
(2001)
Atherosclerosis
, vol.156
, pp. 23-28
-
-
Hsich, E.1
Zhou, Y.F.2
Paigen, B.3
-
43
-
-
1642452661
-
Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation
-
Vliegen I, Duijvestijn A, Grauls G, et al. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation. Microbes Infect 2004; 6:17-24.
-
(2004)
Microbes Infect
, vol.6
, pp. 17-24
-
-
Vliegen, I.1
Duijvestijn, A.2
Grauls, G.3
-
44
-
-
0042490523
-
Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice
-
Lalla E, Lamster IB, Hofmann MA, et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003; 23:1405-1411.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1405-1411
-
-
Lalla, E.1
Lamster, I.B.2
Hofmann, M.A.3
-
45
-
-
0023770125
-
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
-
Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2:983-986.
-
(1988)
Lancet
, vol.2
, pp. 983-986
-
-
Saikku, P.1
Leinonen, M.2
Mattila, K.3
-
46
-
-
0023202743
-
High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
-
Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2:291-293.
-
(1987)
Lancet
, vol.2
, pp. 291-293
-
-
Adam, E.1
Melnick, J.L.2
Probtsfield, J.L.3
-
47
-
-
0037065523
-
Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening
-
Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359:133-135.
-
(2002)
Lancet
, vol.359
, pp. 133-135
-
-
Ishizaka, N.1
Ishizaka, Y.2
Takahashi, E.3
-
48
-
-
0027448539
-
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
-
Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13:1501-1504.
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 1501-1504
-
-
Kuo, C.C.1
Gown, A.M.2
Benditt, E.P.3
Grayston, J.T.4
-
49
-
-
0025125875
-
High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis
-
Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136:23-28.
-
(1990)
Am J Pathol
, vol.136
, pp. 23-28
-
-
Hendrix, M.G.1
Salimans, M.M.2
Van Boven, C.P.3
Bruggeman, C.A.4
-
50
-
-
23944471031
-
Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis
-
Kozarov EV, Dorn BR, Shelburne CE, et al. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005; 25:e17-e18.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
-
-
Kozarov, E.V.1
Dorn, B.R.2
Shelburne, C.E.3
-
51
-
-
0036140702
-
Impact of infectious burden on extent and long-term prognosis of atherosclerosis
-
Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 2002; 105:15-21.
-
(2002)
Circulation
, vol.105
, pp. 15-21
-
-
Espinola-Klein, C.1
Rupprecht, H.J.2
Blankenberg, S.3
-
53
-
-
0034650427
-
Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex
-
Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164:558-561.
-
(2000)
J Immunol
, vol.164
, pp. 558-561
-
-
Ohashi, K.1
Burkart, V.2
Flohe, S.3
Kolb, H.4
-
54
-
-
0036467447
-
Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway
-
Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168:1435-1440.
-
(2002)
J Immunol
, vol.168
, pp. 1435-1440
-
-
Bulut, Y.1
Faure, E.2
Thomas, L.3
-
55
-
-
0035800883
-
Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation
-
Sasu S, LaVerda D, Qureshi N, et al. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001; 89:244-250.
-
(2001)
Circ Res
, vol.89
, pp. 244-250
-
-
Sasu, S.1
Laverda, D.2
Qureshi, N.3
-
56
-
-
0042882763
-
Infections, heat shock proteins, and atherosclerosis
-
Xu Q. Infections, heat shock proteins, and atherosclerosis. Curr Opin Cardiol 2003; 18:245-252.
-
(2003)
Curr Opin Cardiol
, vol.18
, pp. 245-252
-
-
Xu, Q.1
-
57
-
-
0036790571
-
Role of heat shock proteins in atherosclerosis
-
Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 2002; 22:1547-1559.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1547-1559
-
-
Xu, Q.1
-
58
-
-
0038375997
-
Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL
-
Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9:736-743.
-
(2003)
Nat Med
, vol.9
, pp. 736-743
-
-
Binder, C.J.1
Horkko, S.2
Dewan, A.3
-
59
-
-
0142029569
-
Oxidized low density lipoprotein and innate immune receptors
-
Miller YI, Chang MK, Binder CJ, et al. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 2003; 14:437-445.
-
(2003)
Curr Opin Lipidol
, vol.14
, pp. 437-445
-
-
Miller, Y.I.1
Chang, M.K.2
Binder, C.J.3
-
60
-
-
20144385204
-
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages
-
Miller YI, Viriyakosol S, Worrall DS, et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005; 25:1213-1219. This in-vitro study showed that mmLDL can induce release of several pro-inflammatory cytokines from macrophages. For instance, MIP-2 is released by a TLR4-dependent mechanism, while MCP-1 release by mmLDL does not require TLR4.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1213-1219
-
-
Miller, Y.I.1
Viriyakosol, S.2
Worrall, D.S.3
-
61
-
-
0042031044
-
Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero- 3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein
-
Walton KA, Hsieh X, Gharavi N, et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem 2003; 278:29661-29666.
-
(2003)
J Biol Chem
, vol.278
, pp. 29661-29666
-
-
Walton, K.A.1
Hsieh, X.2
Gharavi, N.3
-
62
-
-
14644388840
-
Oxidized phospholipids trigger atherogenic inflammation in murine arteries
-
Furnkranz A, Schober A, Bochkov VN, et al. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Thromb Vasc Biol 2005; 25:633-638.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 633-638
-
-
Furnkranz, A.1
Schober, A.2
Bochkov, V.N.3
-
63
-
-
0037026527
-
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
-
Bochkov VN, Kadl A, Huber J, et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002; 419:77-81.
-
(2002)
Nature
, vol.419
, pp. 77-81
-
-
Bochkov, V.N.1
Kadl, A.2
Huber, J.3
-
64
-
-
10744226347
-
Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2
-
Walton KA, Cole AL, Yeh M, et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 2003; 23:1197-1203.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1197-1203
-
-
Walton, K.A.1
Cole, A.L.2
Yeh, M.3
-
65
-
-
13444280215
-
CD36 is a sensor of diacylglycerides
-
Hoebe K, Georgel P, Rutschmann S, et al. CD36 is a sensor of diacylglycerides. Nature 2005; 433:523-527. This study showed that a CD36-inactivating mutation in mice impairs TLR2-mediated TNF production. This suggests that CD36, a well known receptor implicated in atherosclerosis, may link endogenous lipid ligands to a TLR signaling pathway.
-
(2005)
Nature
, vol.433
, pp. 523-527
-
-
Hoebe, K.1
Georgel, P.2
Rutschmann, S.3
-
66
-
-
27244439205
-
Phosphocholine as a pattern recognition ligand for CD36
-
Boullier A, Friedman P, Harkewicz R, et al. Phosphocholine as a pattern recognition ligand for CD36. J Lipid Res 2005; 46:969-976.
-
(2005)
J Lipid Res
, vol.46
, pp. 969-976
-
-
Boullier, A.1
Friedman, P.2
Harkewicz, R.3
-
67
-
-
11244319578
-
Thematic review series: The immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors
-
Greaves DR, Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 2005; 46:11-20.
-
(2005)
J Lipid Res
, vol.46
, pp. 11-20
-
-
Greaves, D.R.1
Gordon, S.2
-
68
-
-
23644435612
-
Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
-
Moore KJ, Kunjathoor VV, Koehn SL, et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005; 115:2192-2201.
-
(2005)
J Clin Invest
, vol.115
, pp. 2192-2201
-
-
Moore, K.J.1
Kunjathoor, V.V.2
Koehn, S.L.3
-
69
-
-
0034101821
-
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
-
Febbraio M, Podrez EA, Smith JD, et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000; 105:1049-1056.
-
(2000)
J Clin Invest
, vol.105
, pp. 1049-1056
-
-
Febbraio, M.1
Podrez, E.A.2
Smith, J.D.3
-
70
-
-
0030895048
-
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
-
Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997; 386:292-296.
-
(1997)
Nature
, vol.386
, pp. 292-296
-
-
Suzuki, H.1
Kurihara, Y.2
Takeya, M.3
-
71
-
-
33644865172
-
Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo
-
Naik SU, Wang X, Da Silva JS, et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006; 113:90-97.
-
(2006)
Circulation
, vol.113
, pp. 90-97
-
-
Naik, S.U.1
Wang, X.2
Da Silva, J.S.3
-
72
-
-
32944473282
-
Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia
-
Beaven SW, Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 2006; 57:313-329.
-
(2006)
Annu Rev Med
, vol.57
, pp. 313-329
-
-
Beaven, S.W.1
Tontonoz, P.2
-
73
-
-
30444447501
-
Reverse cholesterol transport and cholesterol efflux in atherosclerosis
-
Ohashi R, Mu H, Wang X, et al. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. Qjm 2005; 98:845-856.
-
(2005)
Qjm
, vol.98
, pp. 845-856
-
-
Ohashi, R.1
Mu, H.2
Wang, X.3
-
74
-
-
0242361567
-
Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism
-
Castrillo A, Joseph SB, Vaidya SA, et al. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003; 12:805-816.
-
(2003)
Mol Cell
, vol.12
, pp. 805-816
-
-
Castrillo, A.1
Joseph, S.B.2
Vaidya, S.A.3
-
75
-
-
0037188553
-
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
-
Joseph SB, McKilligin E, Pei L, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A 2002; 99:7604-7609.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 7604-7609
-
-
Joseph, S.B.1
McKilligin, E.2
Pei, L.3
-
76
-
-
0037015013
-
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
-
Tangirala RK, Bischoff ED, Joseph SB, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 2002; 99:11896-11901.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 11896-11901
-
-
Tangirala, R.K.1
Bischoff, E.D.2
Joseph, S.B.3
-
77
-
-
0035571606
-
Immune mechanisms in atherosclerosis
-
Hansson GK. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21:1876-1890.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 1876-1890
-
-
Hansson, G.K.1
-
78
-
-
11144224296
-
Immunomodulation of atherosclerosis: Implications for vaccine development
-
Nilsson J, Hansson GK, Shah PK. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 2005; 25:18-28.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 18-28
-
-
Nilsson, J.1
Hansson, G.K.2
Shah, P.K.3
-
79
-
-
27844541797
-
Control of B-cell responses by Toll-like receptors
-
Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438:364-368.
-
(2005)
Nature
, vol.438
, pp. 364-368
-
-
Pasare, C.1
Medzhitov, R.2
-
80
-
-
8444245925
-
Toll-dependent control mechanisms of CD4 T cell activation
-
Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004; 21:733-741.
-
(2004)
Immunity
, vol.21
, pp. 733-741
-
-
Pasare, C.1
Medzhitov, R.2
-
82
-
-
33646164167
-
TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis
-
Doherty TM, Fisher EA, Arditi M. TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis. Trends Immunol 2006; 27:222-227.
-
(2006)
Trends Immunol
, vol.27
, pp. 222-227
-
-
Doherty, T.M.1
Fisher, E.A.2
Arditi, M.3
-
83
-
-
5644273775
-
Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization
-
Angeli V, Llodra J, Rong JX, et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 2004; 21:561-574.
-
(2004)
Immunity
, vol.21
, pp. 561-574
-
-
Angeli, V.1
Llodra, J.2
Rong, J.X.3
-
84
-
-
4143092691
-
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques
-
Llodra J, Angeli V, Liu J, et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A 2004; 101:11779-11784.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 11779-11784
-
-
Llodra, J.1
Angeli, V.2
Liu, J.3
-
85
-
-
33644852050
-
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice
-
Trogan E, Feig JE, Dogan S, et al. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A 2006; 103:3781-3786.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 3781-3786
-
-
Trogan, E.1
Feig, J.E.2
Dogan, S.3
-
86
-
-
21244448322
-
Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40
-
Bluml S, Kirchberger S, Bochkov VN, et al. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 2005; 175:501-508. This in-vivo study showed that oxidized phospholipids interfere with dendritic cell activation and prevent their maturation. The oxidized phospholipids block TLR-mediated induction of co-stimulatory molecules and cytokine expression.
-
(2005)
J Immunol
, vol.175
, pp. 501-508
-
-
Bluml, S.1
Kirchberger, S.2
Bochkov, V.N.3
|